|
|
Publications and Products
Studies on the Cost of Diabetes
Thomas J Songer, PhD, MSc
Lorraine Ettaro, BS
and the Economics of Diabetes Project Panel
Prepared for Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Division of Diabetes Translation
Atlanta, GA
June 1998
- Introduction
- Why Conduct a Cost-of-Illness Study?
- Actual Uses of Cost-of-Illness Estimates
- Methods Used in Estimating the Cost-of-Illness
- Cost-of-Diabetes Methods
- Cost-of-Diabetes Estimates – Results
- Cost-of-Diabetes Estimates – Comparisons
- Summary
- Limitations in Current Cost-of-Diabetes
Studies
- A Proposed Framework for Future Research
- References
- Estimates of costs of various diseases
- Estimates of the economic cost of diabetes
mellitus in the United States, by study
- Estimates of direct costs for health
care services in diabetes, by study
- Estimates of health care utilization
with data sources, by study
- Cost components included in estimates
of direct health care costs for diabetes
- Estimates of indirect costs due to absenteeism,
disability, and mortality from diabetes, by study
- Comparison of unit costs used by American
Diabetes Association studies for hospital care and nursing home care
- "Prevalence and Costs of Uncured Disease
in the U.S."
- Economic Impact of Alzheimer’s Disease
- Health Care Costs of Various Disorders
- Number of cited cost-of-diabetes studies
by year – January 1983–October 1997
- Number of citations per cost of diabetes
study published
- Direct costs of diabetes in the United
States adjusted by the GDP deflator and prevalence of diabetes
- Attributable risk procedures – ADA
studies
- Appendix A – Price inflation and
diabetes prevalence adjusters
- Appendix B – Direct costs, adjusted
for price inflation, using Gross Domestic Product deflator, and diabetes
prevalence
- Appendix C – Direct costs, adjusted
for price inflation, using Consumer Price Index all items, and diabetes
prevalence
- Appendix D – Direct costs, adjusted
for price inflation, using Consumer Price Index medical care, and diabetes
prevalence
- Appendix E – Direct costs, adjusted
- Appendix F – Economics of Diabetes
Project. Summary and Key Findings of Panel Meeting. April 6-7, 1998,
Atlanta, GA
Acknowledgements
The authors thank Judith Lave and Joseph Newhouse for comments and insight
on the manuscript and access to unpublished data. This work was supported
by the CDC's Division of Diabetes Translation.
Address for correspondence:
|
Thomas J Songer, PhD, MSc
Department of Epidemiology
Graduate School of Public Health
University of Pittsburgh
Pittsburgh, PA 15261 |
Top of page
Historical
Page last modified: December 20, 2005
Content Source: National Center for Chronic Disease Prevention and Health Promotion
Division of Diabetes Translation
|